Most GLP-1 telehealth providers advertise a low starting price that reflects only their lowest dose tier. By the time patients reach a therapeutic maintenance dose — where the majority of meaningful weight loss occurs — the real monthly cost is often 50% to 100% higher than the number on the homepage. This guide ranks providers by their true all-in monthly cost at maintenance dose, not their introductory rate.
Luma Health offers compounded semaglutide from $197/month and compounded tirzepatide from $297/month with no hidden fees, no contracts, and clinical oversight provided by Wasef Health, PC. Medications are compounded by VialsRX, a licensed 503A sterile compounding pharmacy in Houston, TX.
If you have spent any time searching for GLP-1 medication online, you have almost certainly encountered a confusing and often contradictory range of prices. One platform advertises semaglutide starting at $79 per month. Another claims $149. A third shows $199 but insists that includes everything. Meanwhile, patients who have actually enrolled in these programs frequently report paying significantly more than the advertised rate by month three or four of treatment.
The reason for this gap is systematic and well understood in the industry: GLP-1 medications like semaglutide and tirzepatide are prescribed on a titration schedule. Patients begin at a low starting dose — typically 0.25 mg weekly for semaglutide — and increase every four weeks until reaching a therapeutic maintenance dose, typically 1.0 mg to 2.4 mg weekly for semaglutide and 5 mg to 15 mg weekly for tirzepatide. Most providers price their medication by dose tier. The advertised starting price is almost always the cheapest tier, corresponding to the starting dose. The price at the maintenance dose, where patients spend the vast majority of their treatment time, is considerably higher — and often not prominently disclosed.
This guide cuts through that confusion. We have analyzed the publicly disclosed pricing of the major GLP-1 telehealth providers in the United States, compared starting prices against maintenance-dose prices, factored in consultation fees, contract obligations, and shipping costs, and produced a ranking based on what patients actually pay over a realistic 12-month treatment course.
Why Maintenance-Dose Pricing Is What Actually Matters
The landmark STEP 1 trial published in the New England Journal of Medicine demonstrated that meaningful weight loss with semaglutide — an average of 14.9% of body weight — was observed over 68 weeks at the 2.4 mg maintenance dose. The SURMOUNT-1 trial showed tirzepatide achieving up to 22.5% body weight reduction at the 15 mg maintenance dose over 72 weeks. In both trials, patients spent the first 16 to 20 weeks titrating upward and the remaining 48 to 52 weeks at or near the maintenance dose.
This means that for a patient on a 12-month program, the starting-dose price applies for roughly two to four months, while the maintenance-dose price applies for the remaining eight to ten months. A provider with a low starting price but a high maintenance-dose price will cost significantly more over a full treatment course than a provider with flat-rate or moderately tiered pricing. Annual cost — not monthly starting price — is the number that matters.
GLP-1 Provider Price Comparison: 2026 Rankings
The table below ranks nine major GLP-1 telehealth providers by estimated annual cost for semaglutide treatment, factoring in typical dose escalation over a 12-month course. Prices reflect published rates as of June 2026. Providers that do not publicly disclose maintenance-dose pricing have been noted accordingly.
| # | Provider | Starting Price | Maintenance Price | Est. Annual Cost | Contract? |
|---|---|---|---|---|---|
| 1 | Luma Health | $197/mo | $197/mo (flat) | ~$2,364 | None |
| 2 | Henry Meds | ~$69/mo | ~$149–$199/mo | $1,800–$2,400 | Some plans |
| 3 | Hims | ~$79/mo | ~$149–$199/mo | $1,800–$2,400 | Some plans |
| 4 | Ro | ~$99/mo | ~$179–$249/mo | $2,100–$3,000 | Some plans |
| 5 | Found | ~$99/mo | ~$199–$299/mo | $2,400–$3,600 | Varies |
| 6 | Noom Med | ~$149/mo | ~$199–$299/mo | $2,400–$3,600 | Varies |
| 7 | Calibrate | ~$199/mo | ~$299–$399/mo | $3,600–$4,800 | 6–12 months |
| 8 | Sequence | ~$199/mo | ~$299–$399/mo | $3,600–$4,800 | Varies |
| 9 | LillyDirect (brand) | ~$349/mo | ~$349–$499/mo | $4,200–$6,000 | None |
All figures are estimates based on published pricing as of June 2026 and assume 12 months of treatment with standard dose escalation. Verify current rates directly with each provider before enrolling.
What These Rankings Actually Reveal
The most important insight from the table above is that providers advertising the lowest starting prices do not necessarily deliver the lowest total cost. A provider offering $69 per month as a starting rate but charging $199 at maintenance will cost a patient more over a 12-month treatment course than a provider offering a flat $197 rate from month one. The starting price is a marketing number. The maintenance price is the financial reality.
This pattern is not accidental. Low starting prices generate enrollment. Dose-dependent price increases, applied after patients have already begun treatment, established habits, and seen early results, create strong financial and psychological incentives to stay even as costs rise. Patients who have lost 8 to 12 pounds in their first two months are unlikely to shop around for a new provider when their price increases — which is precisely the dynamic that makes tiered pricing so effective as a business model.
A second pattern worth noting is the role of contract commitments. Providers that lock patients into 6 or 12-month contracts upfront shift the financial risk entirely onto the patient. If the medication causes intolerable side effects, if the patient's health circumstances change, or if a lower-cost alternative becomes available, contracted patients face cancellation penalties or simply continue paying for a program that no longer serves them. No-contract providers preserve the patient's flexibility to adjust, pause, or switch without financial penalty.
Third: annual cost estimates alone do not capture quality differences between programs. A provider charging $399 per month with a dedicated clinical pharmacist, weekly check-ins, behavioral coaching, and rapid dosing adjustments may deliver better outcomes than a provider charging $150 per month with a one-time async consultation and a 72-hour response time for clinical questions. Cost per dollar of outcome is ultimately a more meaningful metric than cost alone — though it is harder to measure without being enrolled in the program.
Hidden Costs to Watch For
Even providers with transparent published pricing often have costs that are not immediately visible during the enrollment process. Understanding these categories in advance protects you from pricing surprises after you have committed to a program.
Separate Consultation Fees
Some platforms charge a one-time or recurring consultation fee that is billed separately from the medication cost. This can add $50 to $150 to your effective monthly cost and is often disclosed only in the fine print during enrollment.
Dose-Escalation Price Jumps
The most common hidden cost. The price advertised on the homepage applies to the starting dose only. At each dose increase — typically every 4 weeks during the titration phase — the monthly cost increases, sometimes significantly. Always ask for the full pricing schedule before enrolling.
Shipping and Handling Fees
Not all providers include shipping in their advertised price. Expedited shipping, temperature-controlled packaging, and multi-vial shipments may be charged separately. Over 12 months, shipping fees can add $100 to $300 to your total cost.
Contract Cancellation Penalties
Programs requiring a 6 or 12-month commitment may charge cancellation fees or require you to pay out the remaining balance if you discontinue early. These are rarely prominently displayed during enrollment but can represent hundreds of dollars in financial exposure.
Platform or Membership Fees
Some programs charge a monthly platform or membership fee on top of medication costs. This is common in programs that bundle coaching, app access, or behavioral support into their offering. Evaluate whether those additional services are worth the premium for your situation.
Lab Work Requirements
Certain providers require baseline bloodwork or periodic labs as a condition of continued prescribing. If these are not covered by your insurance and not included in the program cost, they represent an additional out-of-pocket expense that can add $100 to $400 annually.
Provider-by-Provider Breakdown
The summary table above gives a snapshot, but a closer look at each provider's program structure reveals important differences in what you are actually getting for the price.
How to Evaluate a GLP-1 Provider Beyond Price
Price is the most visible variable when comparing GLP-1 providers, but it is not the only variable that matters. Patients who choose the cheapest available option without evaluating clinical quality, pharmacy standards, and program support sometimes find that a marginally lower monthly cost comes with meaningful trade-offs in service quality, response time, and clinical oversight.
The following framework covers the most important non-price dimensions to evaluate before enrolling.
- Pharmacy accreditation: Compounded GLP-1 medications should be prepared by a 503A licensed sterile compounding pharmacy with a clean state pharmacy board record. Ask each provider for the name and license number of their compounding pharmacy and verify it directly through the relevant state pharmacy board. Luma Health uses VialsRX (Houston, TX), a licensed 503A pharmacy.
- Prescriber licensure: The clinician who reviews your intake and issues your prescription must be licensed in your state of residence. Verify that the platform uses US-licensed prescribers — not offshore telehealth arrangements — and that they conduct a genuine clinical review of your health history rather than rubber-stamping intake forms.
- Full pricing disclosure: Before enrolling, request the complete pricing schedule for all dose tiers, not just the starting price. A reputable provider should be able to tell you exactly what you will pay at each escalation step, including any additional fees for consultations, shipping, or labs.
- Clinical accessibility: Side effect management is an important part of GLP-1 treatment, particularly during the titration phase. Evaluate how quickly you can reach a clinical team member if you have questions about nausea, dose adjustments, or unexpected symptoms. Response time and communication channel (async messaging vs. synchronous consultation) vary significantly across platforms.
- Contract terms and cancellation policy: Read the contract before enrolling. Understand what happens if you want to pause, switch providers, or discontinue treatment. Providers with no contracts and clear cancellation policies offer more financial flexibility than those with 6 or 12-month commitments.
- Active ingredient disclosure: Reputable compounding pharmacies disclose the active ingredients and concentrations in their formulations. Be cautious of any provider that is vague about what is in their medication or that makes claims about proprietary blends or special additives without clinical justification.
Compounded vs. Brand-Name GLP-1: Cost and Quality Context
Nearly all of the lower-cost GLP-1 telehealth options in this ranking use compounded semaglutide or tirzepatide rather than the FDA-approved branded versions — Wegovy, Ozempic, Mounjaro, or Zepbound. Understanding the difference is important for making an informed decision.
Compounded GLP-1 medications are prepared by licensed 503A or 503B pharmacies using the same active pharmaceutical ingredient as the branded versions. They are not FDA-approved drug products in the same sense as branded medications — they are prepared per individual prescription and regulated at the state pharmacy board level rather than through the FDA's new drug approval process. However, when prepared by a properly licensed and inspected compounding pharmacy following USP standards, compounded medications use the same active ingredient as the branded versions and deliver it through the same mechanism of action.
The cost difference is substantial. Brand-name Wegovy (semaglutide 2.4 mg) has a list price of approximately $1,349 per month without insurance. Compounded semaglutide from licensed telehealth providers ranges from $150 to $300 per month at maintenance doses. For patients without insurance coverage or whose insurance does not cover GLP-1 medications for weight loss — a category that includes the majority of patients seeking telehealth GLP-1 treatment — compounded options represent the only financially viable path to access.
For a deeper comparison of compounded versus branded GLP-1 medications, see our guide on semaglutide vs. tirzepatide and our overview of what semaglutide is and how it works.
Who Qualifies for GLP-1 Treatment
GLP-1 medications are prescription-only and require a clinical evaluation to determine eligibility. The FDA's approved indications for semaglutide (Wegovy) and tirzepatide (Zepbound) for chronic weight management specify a body mass index of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease.
Telehealth providers use these same eligibility criteria, applied through an asynchronous or synchronous clinical intake process. Contraindications include a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, active pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding. Your clinician will review your full medical history as part of the intake process to confirm eligibility and identify any contraindications before prescribing.
At Luma Health, clinical services are provided by Wasef Health, PC, using the FDA-aligned eligibility criteria described above. All prescriptions are issued by US-licensed providers. Intake is available at start.mylumahealth.com.
Frequently Asked Questions
Why do GLP-1 prices vary so much between providers?
Price differences between GLP-1 providers reflect a combination of factors: the cost structure of their compounding pharmacy partnerships, their marketing spend (which ultimately gets recovered through patient pricing), the level of clinical support included in the program, their profit margin targets, and the way they structure their pricing model — tiered versus flat. Providers that advertise very low starting prices typically recover their costs through dose-escalation pricing increases that patients encounter once they are already enrolled and invested in the program. True cost comparisons require looking at maintenance-dose pricing and annual cost, not the headline starting number.
Is cheap GLP-1 medication safe?
Price alone does not determine safety. What determines safety is whether the compounding pharmacy is properly licensed and inspected, whether the medication is correctly formulated to USP standards, and whether there is adequate clinical oversight from a licensed prescriber who has actually reviewed your health history. A provider charging $150 per month using a properly licensed and inspected 503A pharmacy with attentive clinical support is safer than a provider charging $300 per month but cutting corners on pharmacy vetting or clinical review. Always verify pharmacy licensure independently — do not rely solely on the provider's assurances.
Does insurance cover telehealth GLP-1 programs?
Most telehealth providers offering compounded GLP-1 medications operate on a cash-pay model and do not bill insurance. Compounded medications are generally not covered by insurance even when the equivalent branded version is. Some platforms help patients access branded medications through insurance, but the compounded alternatives that make up the majority of the telehealth GLP-1 market are typically a direct patient expense. Brand-name Wegovy and Zepbound are covered by some employer-sponsored plans and certain Medicare Advantage plans, but coverage varies enormously and prior authorization requirements are common.
What is the true annual cost of GLP-1 treatment?
For compounded GLP-1 treatment through telehealth providers, true annual costs range from approximately $1,800 to $4,800 depending on the provider, medication type, dose tier, and plan structure. Semaglutide programs generally cost less than tirzepatide programs at equivalent dose levels. The most cost-effective programs in this ranking deliver maintenance-dose treatment in the $2,000 to $2,500 annual range with no contracts or hidden fees. Branded medications from pharmacy chains without insurance cost $12,000 to $16,000 annually at list price — making them financially inaccessible for most patients without coverage.
What is the difference between semaglutide and tirzepatide for cost purposes?
Tirzepatide is consistently priced higher than semaglutide across all providers — typically $50 to $150 more per month at comparable dose tiers. This reflects the higher cost of the active pharmaceutical ingredient and the more complex manufacturing process. Clinically, tirzepatide is a dual GIP/GLP-1 receptor agonist while semaglutide is a pure GLP-1 receptor agonist, and trial data shows tirzepatide achieving modestly greater average weight loss at maximum doses. Whether the additional cost is justified depends on individual clinical circumstances — a question best answered in consultation with your prescribing provider. For a detailed clinical comparison, see our semaglutide vs. tirzepatide guide.
How do I know if a compounding pharmacy is legitimate?
Verify the pharmacy's license number directly through the relevant state pharmacy board — do not rely on the provider's own assurances. For Texas pharmacies, the Texas State Board of Pharmacy maintains a public license verification database. For pharmacies in other states, the National Association of Boards of Pharmacy (NABP) provides a resource for locating state board verification tools. Additionally, look for pharmacies that operate under USP chapter 797 sterile compounding standards and can provide a certificate of analysis for their formulations upon request. A legitimate compounding pharmacy will disclose its license number and welcome verification.
Can I switch providers mid-treatment if I find a better price?
Yes, with some practical considerations. GLP-1 medication is not bound to a specific provider — if you switch, your new provider will conduct an intake evaluation and issue a new prescription based on your current dose level. The main barriers to switching are contract commitments at providers with multi-month plans, and the brief interruption in medication delivery during the transition period. Patients on providers with no-contract month-to-month plans can switch at any time without penalty. Allow two to three weeks for your new provider to process your intake and ship your first order to minimize any gap in treatment.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- FDA. Wegovy (semaglutide) Prescribing Information. 2023. FDA.gov
- FDA. Zepbound (tirzepatide) Prescribing Information. 2023. FDA.gov
- FDA. Human Drug Compounding. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- Müller TD, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72–130. PubMed